Loading clinical trials...
Loading clinical trials...
A Phase 1 Study of Trametinib in Combination With Chemoradiation for KRAS Mutant Non-small Cell Lung Cancer
Conditions
Interventions
3-Dimensional Conformal Radiation Therapy
Carboplatin
+6 more
Locations
5
United States
Mayo Clinic in Rochester
Rochester, Minnesota, United States
Case Western Reserve University
Cleveland, Ohio, United States
Ohio State University Comprehensive Cancer Center
Columbus, Ohio, United States
M D Anderson Cancer Center
Houston, Texas, United States
University of Wisconsin Carbone Cancer Center
Madison, Wisconsin, United States
Start Date
October 28, 2013
Primary Completion Date
November 3, 2017
Completion Date
February 24, 2023
Last Updated
May 6, 2023
NCT03191149
NCT06349642
NCT06031688
NCT04151940
NCT02595944
NCT02503722
Lead Sponsor
National Cancer Institute (NCI)
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions